A Multi-Cancer Early Detection (MCED) test is a single blood screening that identifies signals from multiple types of cancer simultaneously, often before symptoms appear. It detects tiny traces of tumor DNA in your bloodstream to help find cancer at its earliest, most treatable stages.
Blessono Specialist Clinic now offers this advanced service, requiring only a simple 10mL blood sample for comprehensive cancer screening.
Distinct from standard screening programs, the Multi-Cancer Early Detection (MCED) test utilizes genomic advancements to detect ctDNA signals associated with the early presence of various cancers. This method offers a minimally invasive solution for pre-symptomatic screening, facilitating prompt medical action when treatment outcomes are optimal. Leveraging SPOT-MAS technology, Blessono Specialist Clinic offers high-precision screening for 10 cancer types, covering Malaysia’s five most common malignancies, with a 78% overall sensitivity (stage-dependent)
“If a positive signal is detected, we can promptly proceed with diagnostic tests (such as an ultrasound scan or blood test) and customised treatment planning.
